KV
Krishna Veni Srikakarlapudi
About Krishna Veni Srikakarlapudi
Data last updated:
Krishna Veni Srikakarlapudi is a Director at Veerat Finance And Investment Limited (since 1994) and Director at Everest Life Sciences Private Limited (since 2017). The companies operate in Financial Services and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹40.2 Lakh; the largest is Veerat Finance And Investment Limited at ₹36.7 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Veerat Finance And Investment Limited U65921TG1994PLC018639 | Director | 27 Oct 1994 | 1994 | ₹36.7 Lakh (FY 2023) | Active |
| Everest Life Sciences Private Limited U51909TG2017PTC117395 | Director | 29 May 2017 | 2017 | ₹3.6 Lakh (FY 2025) | Active |
Board colleagues of Krishna Veni Srikakarlapudi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bangaru Raju Srikakarlapudi | 02235971 | Veerat Finance And Investment Limited | Director |
| Vijaya Kumar Raju Gottumukkala | 05221447 | Veerat Finance And Investment Limited | Director |
| Srikakarlapudi Sirisha | 06921012 | Everest Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Krishna Veni Srikakarlapudi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Krishna Veni Srikakarlapudi
Krishna Veni Srikakarlapudi currently holds 2 directorships: Veerat Finance And Investment Limited (Director, since 27 Oct 1994, revenue ₹36.7 Lakh (FY 2023)); Everest Life Sciences Private Limited (Director, since 29 May 2017, revenue ₹3.6 Lakh (FY 2025)).
Krishna Veni Srikakarlapudi was first appointed on 27 Oct 1994 as Director at Veerat Finance And Investment Limited. The most recent appointment on record is 29 May 2017 at Everest Life Sciences Private Limited.
The 2 current companies of Krishna Veni Srikakarlapudi that report revenue have a combined latest revenue of ₹40.2 Lakh: Veerat Finance And Investment Limited ₹36.7 Lakh (FY 2023); Everest Life Sciences Private Limited ₹3.6 Lakh (FY 2025).
The current boards of Krishna Veni Srikakarlapudi's companies include Bangaru Raju Srikakarlapudi (Veerat Finance And Investment Limited), Vijaya Kumar Raju Gottumukkala (Veerat Finance And Investment Limited), Srikakarlapudi Sirisha (Everest Life Sciences Private Limited).